Chemical and Pharmaceutical Bulletin p. 1287 - 1292 (1997)
Update date:2022-07-29
Topics:
Cuberes, Maria Rosa
Contijoch, Montserrat
Calvet, Carme
Alegre, Julia
Quintana, Jordi Ramon
Frigola, Jordi
New 2-(4-(4-azolylbutyl)piperazinyl)-, 2-(4-(4- azolylbutyl)piperazinylmethyl)- 2-(4-(4-azolylbutyl)homopiperazinyl)- and 2- (4-(4-azolylbutyl)homopiperazinylmethyl)benzimidazoles were synthesized characterized and tested for in vitro and in vivo H1-antihistaminic activity. Structure-activity relationships implied that the best anti histaminic activity required the simultaneous presence of a homopiperazinylbenzimidazole system (or a methylene linker between the benzimidazole and the piperazine rings) and an unsubstituted pyrazole ring. 1-(2-Ethoxyethyl)-2-{4-[4-(pyrazol-1-yl)batyl]homopiperazin-1- yl}benzimidazole (17), as its dimaleate salt, has been chosen for further development.
View MoreContact:+86-10-67147360/67107388
Address:No.18 Guangming Zhongjie, Chongwen District, Beijing, 100061, China
Zhejiang Rongkai Chemical Technology Co.,Ltd.
Contact:+86-578-8185786
Address:Shangjiang Industrial Zone,Suichang
Hangzhou Yanshan Chemical Co.,Ltd.
Contact:86-571- 87698076
Address:Room 1001, #1 Building, Zhongtian MCC, No.2 Youzhinong, Wenyi West Road, Xihu District, Hangzhou, China
xi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Doi:10.1002/ejoc.201402732
(2014)Doi:10.1016/S0040-4039(00)91734-9
(1992)Doi:10.1021/ol3028412
(2012)Doi:10.1021/acs.oprd.0c00428
(2021)Doi:10.1016/0008-6215(83)88038-0
(1983)Doi:10.1021/jo00112a048
(1995)
